Max Healthcare Institute Limited

Max Healthcare Institute Ltd share price gained 1% to Rs 860.0 after the company's net profit jumped 28.33% to Rs 414.45 crore, while revenue from operations slightly gained 8.58% to Rs 2569.21 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.88 lakh crore, easing 7.72%. It has marginally improved by 8.07% over last one week and gained upto 2.85% in last one month while the market capitalization of Max Healthcare Institute Ltd has improved by 5.26% and 21.71% in the same period respectively. Profit before tax (PBT) of Max Healthcare Institute Ltd stood at Rs 540.92 crore in Q3 FY26, rallying 21.27% year-on-year, and expanding by 23.98% quarter-on-quarter. EBITDA came in at Rs 671 crore, surging by 23.67% YoY and jumping 20.19% sequentially. Total expenses grew marginally by 5.05% to Rs 1995.35 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 521.94 crore, inching up 0.15% YoY, while employee benefits expense was at Rs 399.31 crore, ticking higher by 2.87% YoY. For the TTM ended FY26, revenue from operations grew 19.14% to Rs 8373.45 crore, while net profit soared by 34.07% to Rs 1442.41 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 177927% to Rs 2080.21 crore, and PBT registered a growth of 19.14% to Rs 1675.58 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1633.32 crore in FY26, as against Rs 1459.31 crore in FY25. Max Healthcare Institute Ltd crashed 27% in last one year, underperforming the benchmark BSE Sensex which has reduced by 11.78% during the same period.

Max Healthcare Institute Ltd share price gained 0.17% to Rs 851.45 after the company's net profit surged by 28.33% to Rs 414.45 crore, while revenue from operations slightly gained 8.58% to Rs 2569.21 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.88 lakh crore, rising 7.39%. It has marginally improved by 6.60% over last one week and ticked higher by 1.45% in last one month while the market capitalization of Max Healthcare Institute Ltd has inched up 4.22% and 22.49% in the same period respectively. Profit before tax (PBT) of Max Healthcare Institute Ltd stood at Rs 540.92 crore in Q3 FY26, rallying 21.27% year-on-year, and expanding by 23.98% quarter-on-quarter. EBITDA came in at Rs 671 crore, surging by 23.67% YoY and jumping 20.19% sequentially. Total expenses saw a slight increase of 5.05% to Rs 1995.35 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 521.94 crore, posting a minor increase of 0.15% YoY, while employee benefits expense was at Rs 399.31 crore, inching up 2.87% YoY. For the TTM ended FY26, revenue from operations grew 19.14% to Rs 8373.45 crore, while net profit jumped 34.07% to Rs 1442.41 crore, compared to previous TTM. EBITDA jumped by 177927% to Rs 2080.21 crore, and PBT rose 19.14% to Rs 1675.58 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1633.32 crore in FY26, as against Rs 1459.31 crore in FY25. Max Healthcare Institute Ltd nosedived by 28.43% in last one year, underperforming the benchmark BSE Sensex which has slipped by 12.76% during the same period.

Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 16,803 equity shares with a face value of Rs 10 each to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Consequently, the company's paid-up equity share capital increased to Rs 973,32,70,540 from Rs 973,31,02,510.

Max Healthcare Institute Ltd announced that CARE Ratings Limited has upgraded the credit rating for Crosslay Remedies Limited, a wholly-owned material subsidiary of the company, following enhancements to several facilities. Specifically, the Long Term Bank Facilities amounting to Rs 50.00 (enhanced from Rs 40.00) now carry a CARE AA+; Stable rating, with ST facilities reclassified to LT and a Stable outlook assigned; the Long Term Bank Facilities amounting to Rs 1,211.80 (enhanced from Rs 1,000.00) have been rated CARE AA+; Stable, revised from CARE AA+ (CE); Stable; and the Long Term / Short Term Bank Facilities amounting to Rs 105.00 (enhanced from Rs 40.00) now hold a CARE AA+; Stable LT rating, upgraded from CARE AA-; Stable outlook, with the ST rating reaffirmed and removed from Rating Watch with Positive Implications.

Max Healthcare Institute Ltd announced that CARE Ratings Limited has reaffirmed the credit rating of the company, specifically CARE AA+; Stable for Long Term Bank Facilities amounting to Rs 1,818.88 (enhanced from Rs 1,296.02) and CARE A1+ for Short Term Bank Facilities amounting to Rs 80.00, with the communication received on October 8, 2026, at 2.26 pm (IST), and this disclosure will be hosted on the company’s website at www.maxhealthcare.in.

Apollo Hospitals Enterprise Ltd, Fortis Healthcare Ltd, Yatharth Hospital & Trauma Care Services Ltd and Graphite India Ltd are among the other losers in the BSE's 'A' group today, 30 September 2026.Max Healthcare Institute Ltd lost 7.16% to Rs 913.5 at 14:48 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 5.99 lakh shares were traded on the counter so far as against the average daily volumes of 2.54 lakh shares in the past one month.Apollo Hospitals Enterprise Ltd tumbled 7.13% to Rs 8081.35. The stock was the second biggest loser in 'A' group.On the BSE, 2.84 lakh shares were traded on the counter so far as against the average daily volumes of 21014 shares in the past one month.Fortis Healthcare Ltd crashed 7.13% to Rs 760.6. The stock was the third biggest loser in 'A' group.On the BSE, 2.6 lakh shares were traded on the counter so far as against the average daily volumes of 1.47 lakh shares in the past one month.Yatharth Hospital & Trauma Care Services Ltd pared 6.17% to Rs 1037.45. The stock was the fourth biggest loser in 'A' group.On the BSE, 33058 shares were traded on the counter so far as against the average daily volumes of 53202 shares in the past one month.Graphite India Ltd corrected 5.50% to Rs 759.4. The stock was the fifth biggest loser in 'A' group.On the BSE, 1.51 lakh shares were traded on the counter so far as against the average daily volumes of 2.46 lakh shares in the past one month.

Max Healthcare Institute Limited will close the trading window for securities from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s code of conduct.

Max Healthcare Institute Limited announced it received confirmation from Kalinga Hospital Ltd., a subsidiary, of the allotment of 50,21,212 equity shares on a rights basis, representing an infusion of Rs 87.87 crore, increasing Max Healthcare’s shareholding in Kalinga Hospital Ltd. from approximately 58.28% to approximately 66.15%.

Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 33,765 equity shares with a face value of Rs 10 each to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. The allotment, which occurred on September 4, 2026, increased the company’s paid-up equity share capital to Rs 973,31,02,510 and total issued share capital to 97,33,10,251 equity shares.

Max Healthcare Institute Limited announced that its Renewable Energy and Subsidiary Investment Committee approved an additional investment of Rs 87.87 crore by way of subscription to equity shares on a rights basis in Kalinga Hospital Ltd., a subsidiary, to support capital expenditure, modernization, and general corporate requirements, with the transaction expected to be completed within the next 15 days.